Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 396

1.

Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction.

Antoniou T, Prokakis C, Athanasopoulos G, Thanopoulos A, Rellia P, Zarkalis D, Kogerakis N, Koletsis EN, Bairaktaris A.

Ann Thorac Surg. 2012 Sep;94(3):792-8. doi: 10.1016/j.athoracsur.2012.04.046. Epub 2012 Jun 23.

PMID:
22727248
2.

Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.

Antoniou T, Koletsis EN, Prokakis C, Rellia P, Thanopoulos A, Theodoraki K, Zarkalis D, Sfyrakis P.

J Cardiothorac Vasc Anesth. 2013 Jun;27(3):459-66. doi: 10.1053/j.jvca.2012.07.020. Epub 2012 Oct 10.

PMID:
23063102
3.

Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance.

Sablotzki A, Hentschel T, Gruenig E, Schubert S, Friedrich I, Mühling J, Dehne MG, Czeslick E.

Eur J Cardiothorac Surg. 2002 Nov;22(5):746-52.

PMID:
12414041
4.

Inhaled nitric oxide for pulmonary hypertension after heart transplantation.

Ardehali A, Hughes K, Sadeghi A, Esmailian F, Marelli D, Moriguchi J, Hamilton MA, Kobashigawa J, Laks H.

Transplantation. 2001 Aug 27;72(4):638-41.

PMID:
11544423
5.

Postoperative right ventricular failure after left ventricular assist device placement is predicted by preoperative echocardiographic structural, hemodynamic, and functional parameters.

Raina A, Seetha Rammohan HR, Gertz ZM, Rame JE, Woo YJ, Kirkpatrick JN.

J Card Fail. 2013 Jan;19(1):16-24. doi: 10.1016/j.cardfail.2012.11.001.

PMID:
23273590
6.

Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation.

Wagner F, Dandel M, Günther G, Loebe M, Schulze-Neick I, Laucke U, Kuhly R, Weng Y, Hetzer R.

Circulation. 1997 Nov 4;96(9 Suppl):II-291-6.

PMID:
9386113
7.

Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.

Rex S, Schaelte G, Metzelder S, Flier S, de Waal EE, Autschbach R, Rossaint R, Buhre W.

Acta Anaesthesiol Scand. 2008 Jan;52(1):65-72. Epub 2007 Nov 1.

PMID:
17976224
8.

A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension. German PPH study group.

Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W.

J Am Coll Cardiol. 2000 Jan;35(1):176-82.

9.

Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension.

Sablotzki A, Czeslick E, Schubert S, Friedrich I, Mühling J, Dehne MG, Grond S, Hentschel T.

Can J Anaesth. 2002 Dec;49(10):1076-80.

PMID:
12477682
10.

Effects of the HeartMate II continuous-flow left ventricular assist device on right ventricular function.

Lee S, Kamdar F, Madlon-Kay R, Boyle A, Colvin-Adams M, Pritzker M, John R.

J Heart Lung Transplant. 2010 Feb;29(2):209-15. doi: 10.1016/j.healun.2009.11.599.

PMID:
20113911
11.

Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension.

Argenziano M, Choudhri AF, Moazami N, Rose EA, Smith CR, Levin HR, Smerling AJ, Oz MC.

Ann Thorac Surg. 1998 Feb;65(2):340-5.

PMID:
9485226
12.

A comparison of the acute hemodynamic effects of inhaled nitroglycerin and iloprost in patients with pulmonary hypertension undergoing mitral valve surgery.

Yurtseven N, Karaca P, Uysal G, Ozkul V, Cimen S, Tuygun AK, Yuksek A, Canik S.

Ann Thorac Cardiovasc Surg. 2006 Oct;12(5):319-23.

PMID:
17095973
13.

Prediction of right ventricular dysfunction after left ventricular assist device implantation.

Nakatani S, Thomas JD, Savage RM, Vargo RL, Smedira NG, McCarthy PM.

Circulation. 1996 Nov 1;94(9 Suppl):II216-21.

PMID:
8901749
14.

Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.

Topilsky Y, Hasin T, Oh JK, Borgeson DD, Boilson BA, Schirger JA, Clavell AL, Frantz RP, Tsutsui R, Liu M, Maltais S, Kushwaha SS, Pereira NL, Park SJ.

Circ Cardiovasc Imaging. 2011 Nov;4(6):648-61. doi: 10.1161/CIRCIMAGING.111.965335. Epub 2011 Sep 21.

15.
16.

Hemodynamic effects of inhaled nitric oxide and phosphodiesterase inhibitor (dipyridamole) on secondary pulmonary hypertension following heart valve surgery in adults.

Santini F, Casali G, Franchi G, Auriemma S, Lusini M, Barozzi L, Favaro A, Messina A, Mazzucco A.

Int J Cardiol. 2005 Aug 18;103(2):156-63.

PMID:
16080974
17.

Evaluation of pulmonary vascular response to inhaled iloprost in heart transplant candidates with pulmonary venous hypertension.

Braun S, Schrötter H, Schmeisser A, Strasser RH.

Int J Cardiol. 2007 Jan 31;115(1):67-72. Epub 2006 Jun 23.

PMID:
16797747
18.

Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass.

Theodoraki K, Rellia P, Thanopoulos A, Tsourelis L, Zarkalis D, Sfyrakis P, Antoniou T.

Can J Anaesth. 2002 Nov;49(9):963-7.

PMID:
12419726
19.

Inhaled iloprost in eight heart transplant recipients presenting with post-bypass acute right ventricular dysfunction.

Theodoraki K, Tsiapras D, Tsourelis L, Zarkalis D, Sfirakis P, Kapetanakis E, Alivizatos P, Antoniou T.

Acta Anaesthesiol Scand. 2006 Nov;50(10):1213-7. Epub 2006 Sep 15.

PMID:
16978158
20.

Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.

Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM.

Crit Care Med. 2009 Mar;37(3):980-6. doi: 10.1097/CCM.0b013e3181962ce6.

PMID:
19237907
Items per page

Supplemental Content

Write to the Help Desk